Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Aug 22, 2022
Date Accepted: Mar 15, 2023

The final, peer-reviewed published version of this preprint can be found here:

Comparing Adherence to the Experience Sampling Method Among Patients With Schizophrenia Spectrum Disorder and Unaffected Individuals: Observational Study From the Multicentric DiAPAson Project

Zarbo C, Zamparini M, Nielssen O, Casiraghi L, Rocchetti M, Starace F, de Girolamo G, DiAPAson Collaborators

Comparing Adherence to the Experience Sampling Method Among Patients With Schizophrenia Spectrum Disorder and Unaffected Individuals: Observational Study From the Multicentric DiAPAson Project

J Med Internet Res 2023;25:e42093

DOI: 10.2196/42093

PMID: 37463030

PMCID: 10394602

Adherence to Experience Sampling Method (ESM) among Patients with Schizophrenia Spectrum Disorder and Unaffected Controls: an Observational Study from the Multicentric DiAPAson Project

  • Cristina Zarbo; 
  • Manuel Zamparini; 
  • Olav Nielssen; 
  • Letizia Casiraghi; 
  • Matteo Rocchetti; 
  • Fabrizio Starace; 
  • Giovanni de Girolamo; 
  • DiAPAson Collaborators

ABSTRACT

Background:

The Experience Sampling Method (ESM) is a valid method of remotely recording activities, but the predictors of adherence to ESM in patients with Schizophrenia Spectrum Disorders (SSD) are not known.

Objective:

The aim of this study was to compare the adherence to ESM in individuals with SSD and unaffected controls, investigate their patterns, and report on the predictors of adherence.

Methods:

131 patients with SSD (74 in residential facilities and 57 outpatients) and 115 unaffected controls were recruited at ten different centres in Italy, as part of the DiAPAson project. Demographic information, symptom severity, disability level, and level of function were recorded for the clinical sample. Participants were evaluated for daily time use and mood through a smartphone-based ESM 8 times a day for seven days. Adherence was measured by the responses to ESM notifications. Differences were analysed using chi-squared, ANOVA, Kruskall-Wallis and Friedman’s tests, and a logistic regression model.

Results:

Patients with SSD had a lower rate of adherence to ESM when compared to the control group (p <.001), independent of time slot, day of monitoring or the day of the week. The lowest adherence rate was in the late evening (20:00 - 24:00) time slot and days 6-7 of the study for both patients and controls. Higher adherence rate (i.e. ≥ 70%) was predicted by higher collaboration skills (OR= 2.952; p .046) and self-esteem (OR= 3.394; p .029), and lower positive symptoms severity (OR= .835; p .036).

Conclusions:

This study provides important information to guide protocols for future studies employing ESM, including the selection and preparation of participants and the training of clinicians and researchers Clinical Trial: -


 Citation

Please cite as:

Zarbo C, Zamparini M, Nielssen O, Casiraghi L, Rocchetti M, Starace F, de Girolamo G, DiAPAson Collaborators

Comparing Adherence to the Experience Sampling Method Among Patients With Schizophrenia Spectrum Disorder and Unaffected Individuals: Observational Study From the Multicentric DiAPAson Project

J Med Internet Res 2023;25:e42093

DOI: 10.2196/42093

PMID: 37463030

PMCID: 10394602

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.